Amyloid Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Amyloid stocks.

Amyloid Stocks Recent News

Date Stock Title
May 31 LLY Top Research Reports for Eli Lilly, T-Mobile & BHP
May 31 IONS Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
May 31 LLY Is Eli Lilly And Co (NYSE:LLY) the Best Weight Loss Stock to Buy in 2024?
May 31 IONS Ionis hereditary angioedema therapy succeeds in late-stage trials
May 31 IONS Ionis presents positive results from OASIS-HAE and OASISplus studies of investigational medicine donidalorsen in patients with hereditary angioedema
May 31 LLY Goldman Sees Obesity-Drug Market Growing to $130 Billion by 2030
May 31 LLY ZTS, SYK, LLY: Which Healthcare Stock Is the Best Buy?
May 31 NTLA Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And Lackluster Bitcoin Price Action
May 30 LLY Ro CEO on GLP-1 drug shortage: US healthcare is '1 of 1'
May 30 LLY New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk
May 30 LLY 3 Stocks With High Yield Growth For Long-Term Passive Income
May 30 LLY Why Is Lilly (LLY) Up 4.5% Since Last Earnings Report?
May 30 LLY Goldman Sachs raises obesity drug market estimate to $130B
May 30 LLY Costco, Eli Lilly Near New Highs; That Doesn't Scare Mutual Funds
May 30 LLY Urban Outfitters, Eli Lilly And 2 Other Stocks Insiders Are Selling
May 29 LLY Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
May 29 BBIO BridgeBio reports additional positive data for acoramidis in ATTR-CM
May 29 LLY FDA Conditionally Approves Eli Lilly's Thyroid Cancer Drug For Pediatric Patients With Certain Mutations
May 29 BBIO Additional Data Showing Acoramidis Increases Serum Transthyretin Which is Associated with Improved Cardiovascular Outcomes Presented at ISA from BridgeBio Pharma’s Phase 3 ATTRibute-CM Study in Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
May 29 LLY Eli Lilly's Retevmo Gets FDA Accelerated Approval for Kids With RET-altered Thyroid Cancer, Solid Tumors
Amyloid

Amyloids are aggregates of proteins characterised by a fibrillar morphology of 7–13 nm in diameter, a β-sheet secondary structure (known as cross-β) and ability to be stained by particular dyes, such as Congo red. In the human body, amyloids have been linked to the development of various diseases. Pathogenic amyloids form when previously healthy proteins lose their normal structure and physiological functions (misfolding) and form fibrous deposits in plaques around cells which can disrupt the healthy function of tissues and organs.
Such amyloids have been associated with (but not necessarily as the cause of) more than 50 human diseases, known as amyloidosis, and may play a role in some neurodegenerative disorders. Some of these diseases are mainly sporadic and only a few cases are familial. Others are only familial. Some are iatrogenic as they result from medical treatment. One amyloid protein is infectious and is called prion in which the infectious form can act as a template to convert other non-infectious proteins into infectious form. Amyloids may also have normal biological functions; for example, in the formation of fimbriae in some genera of bacteria, transmission of epigenetic traits in fungi, as well as pigment deposition and hormone release in humans.Amyloids have been known to arise from many different proteins. These polypeptide chains generally form β-sheet structures that aggregate into long fibers; however, identical polypeptides can fold into multiple distinct amyloid conformations. The diversity of the conformations may have led to different forms of the prion diseases.

Browse All Tags